The efficacy of NPB in combination with cisplatin29 and PARP inhibitors in ovarian carcinoma (OC)30 and in PTEN-deficient endometrial carcinoma (EC)31 were also recently reported. The gene discussed is PTEN; the disease is endometrial carcinoma.